Sage Therapeutics (Nasdaq: SAGE) announced the publication of a study conducted with collaborators from Massachusetts General Hospital (MGH) on the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE